DOCSLIB.ORG

The Fear of Losing Out

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Fear of Losing Out HEIKKI HIILAMO The Fear of Losing out Tobacco Industry Strategies in Finland 1975–2001 ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Medicine of the University of Tampere, for public discussion in the auditorium of Tampere School of Public Health, Medisiinarinkatu 3, Tampere, on August 24th, 2007, at 12 o’clock. UNIVERSITY OF TAMPERE ACADEMIC DISSERTATION University of Tampere, School of Public Health Finland Supervised by Reviewed by Professor Arja Rimpelä Dr. Jeff Collin University of Tampere University of Edinburgh Docent Matti Rimpelä Docent Sakari Karvonen University of Tampere University of Helsinki Distribution Tel. +358 3 3551 6055 Bookshop TAJU Fax +358 3 3551 7685 P.O. Box 617 [email protected] 33014 University of Tampere www.uta.fi/taju Finland http://granum.uta.fi Cover design by Juha Siro Printed dissertation Electronic dissertation Acta Universitatis Tamperensis 1229 Acta Electronica Universitatis Tamperensis 617 ISBN 978-951-44-6937-4 (print) ISBN 978-951-44-6938-1 (pdf) ISSN 1455-1616 ISSN 1456-954X http://acta.uta.fi Tampereen Yliopistopaino Oy – Juvenes Print Tampere 2007 "Those who cannot remember the past are condemned to repeat it." – George Santayana (1863–1952) 4 List of contents Abstract ......................................................................................................................................................7 Tiivistelmä..................................................................................................................................................9 Abbreviations...........................................................................................................................................11 Original communications ........................................................................................................................12 1. Introduction.........................................................................................................................................13 2 Review of the literature .......................................................................................................................19 2.1 Tobacco industry and tobacco control in Finland........................................................................19 2.2 Tobacco industry document research ..........................................................................................23 2.3 Smoking and health......................................................................................................................26 2.4 Environmental Tobacco Smoke...................................................................................................28 2.5 “Light”, “mild” and “thin” cigarettes ..........................................................................................29 2.6 The properties and effects of nicotine and research on addiction .............................................31 2.7 Research on additives in tobacco products..................................................................................32 2.8 Marketing of tobacco products ....................................................................................................32 2.9 Economics and taxation ..............................................................................................................34 2.10 Industry tactics for resisting public policy on health................................................................35 2.11 Litigation ....................................................................................................................................38 2.12 Strategies outside the USA ........................................................................................................39 2.13 Summary.....................................................................................................................................42 3 Aims of the present study....................................................................................................................43 4 Methods and data.................................................................................................................................45 4.1 Tobacco industry documents .......................................................................................................45 4.2 Search strategies...........................................................................................................................47 4.3 Analysis strategies........................................................................................................................51 5 Results..................................................................................................................................................53 5.1 Tobacco control implication of the first European product liability suit (Paper 1)...................53 5.2 The impact of strategic funding by the tobacco industry of medical expert witnesses appearing for the Defence in the Aho Finnish product liability case (Paper 2)........................56 5.3 Tobacco industry strategy to undermine Tobacco Control Act in Finland (Paper 3)................59 5.4 Tobacco industry documents from outside sources: new perspectives on industry strategies on local levels (Paper 4)..............................................................................................................62 5 6 Discussion ............................................................................................................................................66 7 Conclusions..........................................................................................................................................72 8 Summary ..............................................................................................................................................75 9 Acknowledgements..............................................................................................................................78 10 References..........................................................................................................................................79 Original publications................................................................................................................................92 6 Abstract This study analysed tobacco industry lobbying strategies in Finland from 1975 to 2001. Tobacco industry documents were used as a primary source of data. The study was focused on tobacco control measures in Finland, including product liability litigation against the tobacco companies between 1988 and 2001. The tobacco control implications of tobacco litigation were analysed e.g. by examining the different roles of international tobacco companies and the level of control they employed in the Finnish litigation. The Finnish case was further highlighted through analysis of the possible linkages between tobacco industry’s scientific strategies and its legal defence. With regard to tobacco control measures, the aim was to examine how global tobacco companies have tried to influence tobacco regulation in Finland. The main question was: did the tobacco companies succeed in finding a successful strategy for undermining the development of tobacco control in Finland? Finally, this study explored the validity of the tobacco industry documents by examining whether the material from the private archive of a tobacco lobbyist might augment or revise the earlier reports on tobacco industry manipulation in Finland. This study clearly demonstrated that international tobacco companies considered the legal proceedings in Finland as a global threat. However, tobacco industry tried to play down the importance of the product liability process by portraying it as a local dispute with no international connections. The preparatory work was conducted in committees or groups, which assembled the companies’ internal and external resources and were of crucial significance for the implementation of the defence. The Finnish defence was to be constructed on the same principles as in the USA. Besides using the same argumentation, meaning same terms and descriptions, for example, for general and specific causality, the witnesses were also partly the same. The proceedings revealed that the industry had concealed the health hazards of its products and, despite indisputable evidence, continued to deny them. The positions taken by the industry rocked its reliability as a social actor and thus weakened its chances of influencing tobacco policy. The findings demonstrate that research funding was closely connected to witness development in the product liability case. By granting research funding, the industry had created a pool of experts who were willing either to testify or to recommend other potential medical expert witnesses for the industry. As many as 33 of 45 tobacco industry’s medical 7 expert witnesses received research funding from the industry before or after the testimony. 19 of them worked in different positions as consultants for the industry. The older witnesses testified to the existence of a controversy, which they, in fact, had helped to create. Those appearing in Helsinki District court apparently downplayed the importance of their involvement with the industry. The tobacco industry funded the majority of expert witnesses appearing for it, beyond simple recompense for the time involved. This may have unconsciously influenced the testimony the witnesses gave. The tobacco industry documents
Load more

Recommended publications
  • PL 43 Coût Des Soins De Santé Et Des Dommages- Intérêts Liés Au Tabac
    CAS – 001M C.P. – P.L. 43 Coût des soins de santé et des dommages- intérêts liés au tabac Le 9 juin 2009 Monsieur Geoffrey Kelley Président Commission des affaires sociales Assemblée nationale Québec (Québec) G1A 1A3 Objet : Le projet de loi 43 : Loi sur le recouvrement du coût des soins de santé et des dommages-intérêts liés au tabac Monsieur le président, Au nom de l’Association pour les droits des non-fumeurs, je vous remercie beaucoup de l’occasion que vous nous offrez de témoigner devant vous sur le projet de loi 43 : la Loi sur le recouvrement du coût des soins de santé et des dommages-intérêts liés au tabac. Je vous félicite pour la décision de vous joindre aux autres provinces et territoires au Canada et d’entreprendre des démarches afin de tenir responsable les principaux fabricants de tabac au pays, non seulement pour avoir manqué à leur obligation d’informer le public sur la nocivité de leurs produits, mais surtout pour avoir mis en œuvre une vaste conspiration visant à jeter le doute au sein des législateurs et du public sur les véritables dangers de l’usage du tabac. À notre avis, cette initiative ne vise pas à savoir si les fabricants de tabac ont commis ou non une telle fraude mais plutôt de connaître l’ampleur de celle-ci. Il suffit simplement de jeter un coup d’œil aux documents publiés à ce jour par différentes instances juridiques pour comprendre que la communauté de la santé, dont nous faisons partie, n’exagère en rien lorsqu’elle qualifie d’odieux le comportement de l’industrie du tabac au Canada.
    [Show full text]
  • 1 Rylander Affair Professor Ragnar Rylander Was a Member of The
    Rylander Affair Professor Ragnar Rylander was a member of the faculty at the University of Geneva who did extensive research funded by the tobacco industry. After litigation Rylander lost against two tobacco control advocates (for defamation), the University conducted the equivalent of a UC Privilege and Tenure Hearing. The report was made public. In contrast the to unwillingness of UCORP and others at UC, the Committee viewed the issues in the broader context. As a result of this recommendation, the President of the University of Geneva announced that the university would not longer accept money from the tobacco industry. Here is an announcement of the decision and some associated links: Geneva, Friday October 29, 2004 16h00 local time The University of Geneva just made public a few hours ago its report on the "Affaire Rylander". Here are two excerpts of the summary (translation by PAD), which set the tone of the whole report. "The scientific community and the public must know that Ragnar Rylander's studies on the effects of environmental tobacco smoke on health are marred with serious suspicion, because the author has not revealed his conflicts of interest which were susceptible of influencing the significance of these studies and because he cannot be considered as an independent scientist, considering his role as secret employee of the tobacco industry. The Fact Finding Commission proposes that the following journals be notified of this situation: - European Journal of Public Health; - Archives of Environmental Health; -International Journal of Epidemiology" "Prof. Rylander's multiple breaches of scientific integrity take their full significance only when placed in the framework of the strategy conceived and carried out by the tobacco industry to throw doubt on the toxicity of tobacco smoke, particularly for the non-smokers.
    [Show full text]
  • Motor Vehicle Air Pollution
    wHotPEPt92.4 Distr:Limited Original:English Motor Vehicle Air Pollution Public Health Impact and Control Measures Editedby David Mage and Olivier Zali Division of EnvironmentalHealth EcotoxicologyService World HealthOrganization Departmentof PublicHealth Geneva,Switzedand Republicand Cantonof Geneva Geneva,Switzerland @ World HealthOrganization and ECOTOX ,lgg2 This documentis not issuedto the generalpublic, and all rights are reservedby the World HealthOrganization (WHO) andthe Serviceof Ecotoxicology (ECOTOX)of the Departmentof PublicHealth, Geneva. The documentmay be reviewed,abstracted, quoted, reproduced or translated,in part or in whole, with the prior written permissionof WHO or ECOTOX. Partsof this documentmay be storedin a retrievalsystem or transmittedin any form or by any means- electronic,mechanical or other- with the prior written permissionof WHO or ECOTOX. The views expressedin the documentby namedauthors are solelythe responsibilityof thoseauthors. The geographicaldesignations employed and the presentationof materialin this documentdo not imply the expressionof any opinionwhatsoever on the part of WHO concerningthe legal statusof any country,territory, city or areaof its authorities,or concerningthe delimitationof its frontiersor boundaries. Credits:cover photograph of Genevaby E.J. Aldag @.J. Press),Geneva; cover photographof Mexico City by ASL, Lausanne;stamp design, copyright Sweden PostStamps. MOTOR VEHICLE AIR POLLUTION PTJBLICHEALTII IMPACT AND CONTROLMEASURES Contents Page Foreword- Wilfried Kreiseland Guy-OlivierSegond v Executivesummary vii 1.Introduction.... 1 2. Review of the health effectsof motor vehicle traffic . 13 - Part I. Epidemiologicalstudies of the healtheffects of air pollutiondue to motorvehicles - IsabelleRomieu 13 - Part II. Effectson humansof environmentalnoise particutarly from road traffic - RagnarRylander 63 3. Humanexposure to motor vehicleair pollutants- PeterG. Flachsbart 85 4. Reviewof motor vehicleemission control mqNures andtheir effectiveness- Michael P. Walsh 115 5.
    [Show full text]
  • Advances in APPLIED MICROBIOLOGY
    Advances in APPLIED MICROBIOLOGY VOLUME 69 Advances in APPLIED MICROBIOLOGY VOLUME 69 Edited by ALLEN I. LASKIN Somerset, New Jersey, USA SIMA SARIASLANI Wilmington, Delaware, USA GEOFFREY M. GADD Dundee, Scotland, UK AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 32, Jamestown Road, London NW1 7BY, UK First edition 2009 Copyright # 2009 Elsevier Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negli- gence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made ISBN: 978-0-12-374824-9 ISSN: 0065-2164 For information on all Academic Press publications visit our website at www.elsevierdirect.com Printed and bound in the USA 091010987654321 CONTENTS Contributors ix 1.
    [Show full text]
  • Stop Smoking Systems BOOK
    Stop Smoking Systems A Division of Bridge2Life Consultants BOOK ONE Written by Debi D. Hall |2006 IMPORTANT REMINDER – PLEASE READ FIRST Stop Smoking Systems is Not a Substitute for Medical Advice: STOP SMOKING SYSTEMS IS NOT DESIGNED TO, AND DOES NOT, PROVIDE MEDICAL ADVICE. All content, including text, graphics, images, and information, available on or through this Web site (“Content”) are for general informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis or treatment. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE, OR DELAY IN SEEKING IT, BECAUSE OF SOMETHING YOU HAVE READ IN THIS PROGRAMMATERIAL. NEVER RELY ON INFORMATION CONTAINED IN ANY OF THESE BOOKS OR ANY EXERCISES IN THE WORKBOOK IN PLACE OF SEEKING PROFESSIONAL MEDICAL ADVICE. Computer Support Services Not Liable: IS NOT RESPONSIBLE OR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS OR ANY OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN THROUGH THIS SITE. Confirm Information with Other Sources and Your Doctor: You are encouraged to confer with your doctor with regard to information contained on or through this information system. After reading articles or other Content from these books, you are encouraged to review the information carefully with your professional healthcare provider. Call Your Doctor or 911 in Case of Emergency: If you think you may have a medical emergency, call your doctor or 911 immediately. DO NOT USE THIS READING MATERIAL OR THE SYSTEM FOR SMOKING CESSATION CONTAINED HEREIN FOR MEDICAL EMERGENCIES. No Endorsements: Stop Smoking Systems does not recommend or endorse any specific tests, products, procedures, opinions, physicians, clinics, or other information that may be mentioned or referenced in this material.
    [Show full text]
  • Finnish Studies
    JOURNAL OF FINNISH STUDIES Volume 16 Number 1 August 2012 Journal of Finnish Studies JOURNAL OF FINNISH STUDIES EDITORIAL AND BUSINESS OFFICE Journal of Finnish Studies, Department of English, 1901 University Avenue, Evans 458 (P.O. Box 2146), Sam Houston State University, Huntsville, TEXAS 77341-2146, USA Tel. 1.936.294.1402; Fax 1.936.294.1408 SUBSCRIPTIONS, ADVERTISING, AND INQUIRIES Contact Business Office (see above & below). EDITORIAL STAFF Helena Halmari, Editor-in-Chief, Sam Houston State University; [email protected] Hanna Snellman, Co-Editor, University of Helsinki; [email protected] Scott Kaukonen, Associate Editor, Sam Houston State University; [email protected] Hilary Joy Virtanen, Assistant Editor, University of Wisconsin; [email protected] Sheila Embleton, Book Review Editor, York University; [email protected] EDITORIAL BOARD Varpu Lindström, University Professor, York University, Toronto, Chair Börje Vähämäki, Founding Editor, JoFS, Professor Emeritus, University of Toronto Raimo Anttila, Professor Emeritus, University of California, Los Angeles Michael Branch, Professor Emeritus, University of London Thomas DuBois, Professor, University of Wisconsin Sheila Embleton, Distinguished Research Professor, York University, Toronto Aili Flint, Emerita Senior Lecturer, Associate Research Scholar, Columbia University, New York Anselm Hollo, Professor, Naropa Institute, Boulder, Colorado Richard Impola, Professor Emeritus, New Paltz, New York Daniel Karvonen, Senior Lecturer, University of Minnesota, Minneapolis Andrew Nestingen,
    [Show full text]
  • The Adverse Health Effects of Smoking and the Tobacco Industry’S Efforts to Limit Tobacco Control
    THE ADVERSE HEALTH EFFECTS OF SMOKING AND THE TOBACCO INDUSTRY’S EFFORTS TO LIMIT TOBACCO CONTROL Prepared by: Jonathan M. Samet, MD, MS Director, USC Institute for Global Health Distinguished Professor and Flora L. Thornton Chair, Department of Preventive Medicine, Keck School of Medicine of USC University of Southern California 2001 North Soto Street, Suite 330A Los Angeles, California 90089-9239, USA Phone: +1 323 865 0803 Fax: +1 323 865 0854 Email: [email protected] 1 Table of Contents Summary ....................................................................................................................................................... 4 Professional Qualifications ........................................................................................................................... 6 Approach ....................................................................................................................................................... 9 Introduction and Context ............................................................................................................................ 10 Scientific approaches to smoking and health ......................................................................................... 11 Epidemiological research ........................................................................................................................ 14 Identifying causes of disease................................................................................................................... 15 The
    [Show full text]
  • Kkaubamärgileht
    ISSN2228-3587 EESTIVABARIIK EESTI KKAUBAMÄRGILEHT PPAA 10 E E T S E TI M PATENDIA 2016 PATENDIAMETIAMETLIKVÄLJAANNE TALLINN ISSN2228-3587 EESTIVABARIIK EESTI KKAUBAMÄRGILEHT PATENDIAMETI AMETLIKVÄLJAANNE XXIVaastakäik Käesolevasnumbris 10 esitatudandmed loetakseavaldatuks 2016 3.oktoobril2016.a. OKTOOBER TALLINN Eesti Kaubamärgilehte antakse välja kaubamärgiseaduse paragrahvi 40 ja geograafilise tähise kaitse seaduse paragrahv 22 lõike 3 alusel. The Estonian Trade Mark Gazette is the official publication of the Estonian Patent Office published under § 40 of the Trade Marks Act and under § 22(3) of the Geographical Indications Protection Act of the Republic of Estonia. The data presented in this issue is deemed to be published on 3 October 2016. Patendiameti The Registry Department registriosakond of the Estonian Patent Office Toompuiestee 7 Toompuiestee 7 15041 Tallinn 15041 Tallinn, ESTONIA Tel 627 7907 Phone +372 627 7907 Faks 627 7943 Fax +372 627 7943 E-post [email protected] E-mail [email protected] © Patendiamet, 2016 EESTI KAUBAMÄRGILEHT 10/2016 3 SISUKORD CONTENTS Andmete identifitseerimise rahvusvahelised numberkoodid (INID-koodid)...............................................................5 Internationally Agreed Numbers for the Identification of Data (INID Codes) Riikide, teiste ühenduste ja valitsustevaheliste organisatsioonide koodid...................................................................6 List of Codes of States, Other Entities and Intergovernmental Organizations I. KAUBAMÄRGI REGISTREERIMISE OTSUSE TEATED......................................................................................7
    [Show full text]
  • Red Canaries En.Pdf
    A Life Redirected The Story of an Illness Consensus and C a n a r i e s About Medical Science and its Loyalties Two articles by Karl-Erik Tallmo This is a special PDF version of two articles by Karl-Erik Tallmo, from issue no 23 of web magazine The Art Bin, published 7 January, 2003. Addresses to WWW pages are included in this version primarily in cases when a reference is available on the web only and not in print. The HTML versions of these articles contain many more URL’s than the PDF. See http://www.art-bin.com/art/redirected_en.html http://www.art-bin.com/art/canaries_en.html © Karl-Erik Tallmo, Nisus Publishing, 2003 C o n t e n t s There are no subheadings in the articles, but the following clickable key- word links will guide the reader to various topics in the text. A Life Redirected 7 The outbreak and the first nine years 7 Being chronically ill changes your whole life 40 Celebrities with CFS etc 45 Consensus and Canaries 53 ”Non-specific symptoms” and somatization 54 Scientific research: risk assessment and health alerts 68 Consensus 71 Scientists as industry consultants 76 Controversial scientists 78 The thalidomide scandal 84 Research infiltrated by the tobacco industry 94 EGIL – the Nordic branch 102 The Ragnar Rylander affair 108 The PVC industry 113 Individual susceptibility and limit values 120 Three positive happenings 126 A Life Redirected The Story of an Illness s I woke up one morning in May 1993, everything changed. Life A changed.
    [Show full text]
  • Die Kunst, Blauen Dunst Zu Vermarkten
    BACHELORARBEIT Frau Jana Fasler Verbotene Werbung – Die Kunst, blauen Dunst zu vermarkten Mittweida, 2011 Fakultät Medien BACHELORARBEIT Verbotene Werbung – Die Kunst, blauen Dunst zu vermarkten Autor: Frau Jana Fasler Studiengang: Business Management Seminargruppe: BM08w2-B Erstprüfer: Prof. Dr. phil. Ludwig Hilmer Zweitprüfer: Sandra Hahn M.A. Soziologie Einreichung: Mittweida, 20.07.2011 Verteidigung/Bewertung: Mittweida, 2011 Faculty Media BACHELOR THESIS Forbidden Advertising – Selling cigarette smoke author: Ms. Jana Fasler course of studies: Business Management seminar group: BM08w2-B first examiner: Prof. Dr. phil. Ludwig Hilmer second examiner: Sandra Hahn M.A. Soziologie submission: Mittweida, 20.07.2011 defence/ evaluation: Mittweida, 2011 Bibliografische Beschreibung: Fasler, Jana: Verbotene Werbung – Die Kunst, blauen Dunst zu vermarkten. - 2011. - XX, 72 S. Mittweida, Hochschule Mittweida, Fakultät Medien, Bachelorarbeit, 2011 Referat: Tabak hat wie kein anderes Konsumgut über Jahrhunderte eine extreme Wand- lung vollzogen – von der einstigen Heilpflanze des Orients, zum anerkannten Suchtmittel, bis hin zur propagierten Ursache einer weltweiten Epidemie. Nach- dem die BRD vergeblich gegen die EU-Richtlinie geklagt hatte, wurde diese im Jahr 2007 in Deutschland in nationales Recht umgesetzt. Damit trat das Werbe- verbot für Tabakerzeugnisse in Kraft, welches eine Vielzahl von Vermarktungs- kanälen massiv einschränkt. Zudem ist derzeit die EU-Tabakproduktrichtlinie in einem umstrittenen Revisionsverfahren, wonach bald mit zusätzlichen Restrik- tionen zur Tabakvermarktung zu rechnen ist. Aus aktuellem Anlass untersucht die vorliegende Arbeit die Tabakwerbung, mit dem Fokus alternative Wege und Strategien der Tabakhersteller bei der Vermarktung ihrer Produkte aufzuzeigen. Der Schwerpunkt liegt hierbei in der Untersuchung von Vermarktungskonzepten der BTL-Ebene für das Produktsegment der Zigarette, da diese nachweislich das konsum- und absatzstärkste Tabakprodukt weltweit darstellt.
    [Show full text]
  • PREPARE YOUR CONGRESS Advance Programme
    HELP SHAPE THE FUTURE OF RESPIRATORY SCIENCE AND MEDICINE PREPARE YOUR CONGRESS Advance Programme TAKE PART IN ERS LONDON 2016 ERSCONGRESS. ORG PROGRAMME AT A GLANCE REGISTRATION FEES Early bird (until 12 Standard (13 July to Onsite (from 3 July 2016) 2 September 2016) September 2016) Postgraduate courses € 95 € 125 € 140 Full day postgraduate course € 155 € 200 € 220 Challenging clinical cases € 70 € 90 € 100 Meet the expert € 70 € 90 € 100 Educational skills workshops € 70 € 90 € 100 Professional development € 25 € 35 € 40 worshops ERS International Congress 2016 OUTLINE PROGRAMME SATURDAY 03 SEPTEMBER, 2016 SATURDAY 03 SEPTEMBER 2016 EPIDEMIOLOGY/ START END TYPE SESSION TAG IMPORTANT INFORMATION ENVIRONMENT 08:00 10:20 Skills workshop SW1 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 INFECTION standard or €70 for early bird registration. INTENSIVE CARE 10:40 13:00 Skills workshop SW2 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 ONCOLOGY standard or €70 for early bird registration. PAEDIATRIC 14:30 16:50 Skills workshop SW3 Inhaler techniques Clinical Registration for this session is additional to the congress registration fee and is €100 on site, €90 PHYSIOLOGY standard or €70 for early bird registration. 09:30 17:30 Postgraduate PG1 Asthma and chronic Clinical Registration for this session is additional to the SLEEP Course obstructive pulmonary disease Translational congress registration fee and is €220 on site, €200 standard or €155 for early bird registration. An update in assessment and INDUSTRY treatment 09:30 17:30 Postgraduate PG2 Advanced thoracic Clinical Registration for this session is additional to the Course ultrasound congress registration fee and is €220 on site, Enhance your sonography €200 standard or €155 for early bird registration.
    [Show full text]
  • Kkaubamärgileht
    ISSN1022-0852 EESTIVABARIIK EESTI KKAUBAMÄRGILEHT PPAA 8 E E T S E TI M PATENDIA 2012 PATENDIAMETIAMETLIKVÄLJAANNE TALLINN ISSN1022-0852 EESTI VABARIIK EESTI KKAUBAMÄRGILEHT PATENDIAMETI AMETLIKVÄLJAANNE XXaastakäik Käesolevasnumbris esitatudandmed 8 loetakseavaldatuks 2012 . 1.augustil2012 a. AUGUST TALLINN Eesti Kaubamärgilehte antakse välja kaubamärgiseaduse (jõustunud 01.05.2004) ja geograafilise tähise kaitse seaduse (jõustunud 10.01.2000) alusel. The Estonian Trademark Gazette is the official publication of the Estonian Patent Office. Published under the Trademark Act (entered into force 1 October 1992) and the Geographical Indication Protection Act (entered into force 10 January 2000). Date of publication - 1 August 2012. Patendiameti The Information Department infoosakond of the Estonian Patent Office Toompuiestee 7 Toompuiestee 7 15041 Tallinn 15041 Tallinn, ESTONIA Tel 627 7907 Phone +372 627 7907 Faks 627 7943 Fax +372 627 7943 E-post [email protected] E-mail [email protected] Levitaja Distributor Patendiinfo keskus Estonian Patent Information Centre Olevimägi 8/10 Olevimägi 8/10 10123 Tallinn 10123 Tallinn, ESTONIA Tel 641 1248 Phone +372 641 1248 Faks 641 1018 Fax +372 641 1018 E-post [email protected] E-mail [email protected] © Patendiamet, 2012 EESTI KAUBAMÄRGILEHT 8/2012 3 SISUKORD CONTENTS Andmete identifitseerimise rahvusvahelised Internationally Agreed Numbers for the numberkoodid (INID-koodid) ................. 5 Identification of Data (INID Codes) . 5 Riikide, teiste ühenduste ja valitsustevaheliste List of Codes of States, Other Entities and organisatsioonide koodid .................... 6 Intergovernmental Organizations . 6 I. KAUBAMÄRGI REGISTREERIMISE I. NOTICES OF DECISIONS TO REGISTER OTSUSE TEATED.........................7 A TRADEMARK ..........................7 Kaubamärgi registreerimise otsuse teadete Amendments and Corrections to Notices of muudatused ja parandused ................... - Decisions to Register a Trademark .
    [Show full text]